Literature DB >> 22565952

Hypoxia-activated prodrugs forge ahead in cancer.

Jim Kling.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22565952     DOI： 10.1038/nbt0512-381

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  6 in total

Review 1.  F-18 fluoromisonidazole for imaging tumor hypoxia: imaging the microenvironment for personalized cancer therapy.

Authors:  Joseph G Rajendran; Kenneth A Krohn
Journal:  Semin Nucl Med       Date:  2015-03       Impact factor: 4.446

2.  Hypoxia-targeted siRNA delivery.

Authors:  F Perche; S Biswas; T Wang; L Zhu; V P Torchilin
Journal:  Angew Chem Int Ed Engl       Date:  2014-02-19       Impact factor: 15.336

Review 3.  Interactions of ion transporters and channels with cancer cell metabolism and the tumour microenvironment.

Authors:  Anne Poder Andersen; José M A Moreira; Stine Falsig Pedersen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-02-03       Impact factor: 6.237

Review 4.  Stimuli-responsive nanoparticles for targeting the tumor microenvironment.

Authors:  Jinzhi Du; Lucas A Lane; Shuming Nie
Journal:  J Control Release       Date:  2015-09-01       Impact factor: 9.776

5.  Artificial tumor microenvironment regulated by first hemorrhage for enhanced tumor targeting and then occlusion for synergistic bioactivation of hypoxia-sensitive platesomes.

Authors:  Wenhui Tao; Dongyang Zhao; Guanting Li; Lingxiao Li; Songhao Li; Hao Ye; Chutong Tian; Yutong Lu; Shuying Li; Yinghua Sun; Zhonggui He; Jin Sun
Journal:  Acta Pharm Sin B       Date:  2021-08-12       Impact factor: 14.903

6.  MR Imaging Biomarkers to Monitor Early Response to Hypoxia-Activated Prodrug TH-302 in Pancreatic Cancer Xenografts.

Authors:  Xiaomeng Zhang; Jonathan W Wojtkowiak; Gary V Martinez; Heather H Cornnell; Charles P Hart; Amanda F Baker; Robert Gillies
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.